| An international multicenter cohort study on β-blockers for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia PJ Peltenburg, D Kallas, JM Bos, KVV Lieve, S Franciosi, TM Roston, ... Circulation 145 (5), 333-344, 2022 | 41 | 2022 |
| Clinical and functional characterization of ryanodine receptor 2 variants implicated in calcium-release deficiency syndrome TM Roston, J Wei, W Guo, Y Li, X Zhong, R Wang, JP Estillore, ... JAMA cardiology 7 (1), 84-92, 2022 | 33 | 2022 |
| Burst exercise testing can unmask arrhythmias in patients with incompletely penetrant catecholaminergic polymorphic ventricular tachycardia TM Roston, D Kallas, B Davies, S Franciosi, AM De Souza, ZW Laksman, ... Clinical Electrophysiology 7 (4), 437-441, 2021 | 30 | 2021 |
| Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia D Kallas, TM Roston, S Franciosi, L Brett, KVV Lieve, SY Kwok, ... Heart Rhythm 18 (11), 1825-1832, 2021 | 17 | 2021 |
| Pediatric catecholaminergic polymorphic ventricular tachycardia: a translational perspective for the clinician-scientist D Kallas, A Lamba, TM Roston, A Arslanova, S Franciosi, GF Tibbits, ... International journal of molecular sciences 22 (17), 9293, 2021 | 11 | 2021 |
| Flecainide is associated with a lower incidence of arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia AT Bergeman, KVV Lieve, D Kallas, JM Bos, F Rosés i Noguer, I Denjoy, ... Circulation 148 (25), 2029-2037, 2023 | 5 | 2023 |
| Use of digital health technology in heart failure and diabetes: a scoping review D Kallas, N Sandhu, C Gandilo, M Schleicher, L Banks, M Jabara, ... Journal of Cardiovascular Translational Research 16 (3), 526-540, 2023 | 5 | 2023 |
| The emerging role of digital health technology in cardiovascular care Y Qiu, CY Asselin, D Kallas, N Adreak, K Armstrong, TJF Colella, ... Canadian Journal of Cardiology 37 (7), 939-942, 2021 | 4 | 2021 |
| An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular … A Lamba, TM Roston, PJ Peltenburg, D Kallas, S Franciosi, KVV Lieve, ... Heart Rhythm, 2024 | 3 | 2024 |
| Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia PJ Peltenburg, LM van den Heuvel, D Kallas, C Bell, I Denjoy, ER Behr, ... Europace 26 (2), euae044, 2024 | 2 | 2024 |
| PO-03-157 activity restriction in pediatric catecholaminergic polymorphic ventricular tachycardia: does it matter what the doctor says? D Kallas, S Franciosi, C Voss, T Tavacova, P Kubus, PJ Kannankeril, ... Heart Rhythm 20 (5), S436-S437, 2023 | 1 | 2023 |
| An online international survey study into the incidence and potential reasons of therapy non-adherence in catecholaminergic polymorphic ventricular tachycardia: preliminary results P Peltenburg, LM Van Den Heuvel, D Kallas, V Probst, NA Blom, ... European Heart Journal 44 (Supplement_2), ehad655. 625, 2023 | | 2023 |
| Calcium Release Deficiency Syndrome: A New Inherited Arrhythmia Syndrome. D Kallas, JD Roberts, S Sanatani, TM Roston Cardiac Electrophysiology Clinics 15 (3), 319-329, 2023 | | 2023 |
| Late Palpitations in Young Patients After Ablation for Tachyarrhythmias COY Li, D Kallas, L LePoidevin, A Hart, S Franciosi, S Sanatani CJC Pediatric and Congenital Heart Disease 2 (3), 106-111, 2023 | | 2023 |
| Flecainide is associated with a reduction in arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia AT Bergeman, MW Tanck, D Kallas, S Sanatani, A Leenhardt, ... Europace 25 (Supplement_1), euad122. 301, 2023 | | 2023 |
| High Prevalence of Neurodevelopmental Disorders in Pediatric Long QT Syndrome: A Single Centre Experience S Sanatani, A Lamba, D Kallas, S Gu, S Singh, S Franciosi Authorea Preprints, 2022 | | 2022 |
| PO-655-05 IS ANKYRIN-2 A POTENTIAL GENETIC MODIFIER IN PEDIATRIC CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA? D Kallas, JM Bos, P Peltenburg, S Franciosi, A Mohajeri, M Cheung, ... Heart Rhythm 19 (5), S264-S265, 2022 | | 2022 |
| PO-714-04 HIGH PREVALENCE OF NEURODEVELOPMENTAL DISORDERS IN PEDIATRIC LONG QT SYNDROME PATIENTS A Lamba, D Kallas, S Gu, S Singh, S Franciosi, S Sanatani Heart Rhythm 19 (5), S489, 2022 | | 2022 |
| PE-568-04 A DISTINCT AND POTENTIALLY MORE SEVERE NEUROCARDIAC PHENOTYPE AMONG PEDIATRIC PATIENTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA CY Miyake, D Kallas, PS Fischbach, MJ LaPage, IH Law, AC Hill, ... Heart Rhythm 19 (5), S80, 2022 | | 2022 |
| B-PO05-167 ATRIAL TACHYARRHYTHMIAS IN CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA: A REPORT FROM THE INTERNATIONAL PEDIATRIC CPVT REGISTRY D Kallas, R Ghadiry-Tavi, TM Roston, S Franciosi, PS Fischbach, ... Heart Rhythm 18 (8), S440, 2021 | | 2021 |
